The Association Between Low 50 g Glucose Challenge Test Values and Adverse Pregnancy Outcomes.
- Published in:
- Journal of Women's Health (15409996), 2018, v. 27, n. 6, p. 801, doi. 10.1089/jwh.2017.6579
- By:
- Publication type:
- Article
Works matching AU Byung Wan Lee
Results: 157
1
2
Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 259, doi. 10.3390/jcm9010259
- By:
- Publication type:
- Article
3
Proteinuria Is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 136, doi. 10.3390/jcm9010136
- By:
- Publication type:
- Article
4
The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1645, doi. 10.3390/jcm8101645
- By:
- Publication type:
- Article
5
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30409-6
- By:
- Publication type:
- Article
6
Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008-2011).
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0436-z
- By:
- Publication type:
- Article
7
Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes.
- Published in:
- Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12933-015-0219-y
- By:
- Publication type:
- Article
8
Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance.
- Published in:
- Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 83, doi. 10.1186/1475-2840-11-83
- By:
- Publication type:
- Article
9
Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2012, v. 11, n. 1, p. 84, doi. 10.1186/1475-2840-11-84
- By:
- Publication type:
- Article
10
Effect of hypoxia-inducible VEGF gene expression on revascularization and graft function in mouse islet transplantation.
- Published in:
- Transplant International, 2011, v. 24, n. 3, p. 307, doi. 10.1111/j.1432-2277.2010.01194.x
- By:
- Publication type:
- Article
11
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study.
- Published in:
- Diabetologia, 2019, v. 62, n. 5, p. 779, doi. 10.1007/s00125-019-4829-x
- By:
- Publication type:
- Article
12
Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1c with Time.
- Published in:
- 2015
- By:
- Publication type:
- journal article
13
Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
- By:
- Publication type:
- Article
14
A 52‐week efficacy and safety study of enavogliflozin versus dapagliflozin as an add‐on to metformin in patients with type 2 diabetes mellitus: ENHANCE‐M extension study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2248, doi. 10.1111/dom.15537
- By:
- Publication type:
- Article
15
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1105, doi. 10.1111/dom.14679
- By:
- Publication type:
- Article
16
Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 4, p. 752, doi. 10.1111/dom.14623
- By:
- Publication type:
- Article
17
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1041, doi. 10.1111/dom.14310
- By:
- Publication type:
- Article
18
Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 609, doi. 10.1111/dom.14259
- By:
- Publication type:
- Article
19
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.
- Published in:
- Thyroid, 2018, v. 28, n. 7, p. 864, doi. 10.1089/thy.2017.0550
- By:
- Publication type:
- Article
20
Continued Suppression of Serum TSH Level May Be Attributed to TSH Receptor Antibody Activity As Well As the Severity of Thyrotoxicosis and the Time to Recovery of Thyroid Hormone in Treated Euthyroid Graves' Patients.
- Published in:
- Thyroid, 2006, v. 16, n. 12, p. 1251, doi. 10.1089/thy.2006.16.1251
- By:
- Publication type:
- Article
21
The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128627
- By:
- Publication type:
- Article
22
Inverse Association between Glycated Albumin and Insulin Secretory Function May Explain Higher Levels of Glycated Albumin in Subjects with Longer Duration of Diabetes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108772
- By:
- Publication type:
- Article
23
Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107584
- By:
- Publication type:
- Article
24
Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095729
- By:
- Publication type:
- Article
25
The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089478
- By:
- Publication type:
- Article
26
Human Monoclonal Antibodies against Glucagon Receptor Improve Glucose Homeostasis by Suppression of Hepatic Glucose Output in Diet-Induced Obese Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050954
- By:
- Publication type:
- Article
27
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04017-x
- By:
- Publication type:
- Article
28
The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function.
- Published in:
- Clinical Endocrinology, 2012, v. 77, n. 5, p. 679, doi. 10.1111/j.1365-2265.2011.04312.x
- By:
- Publication type:
- Article
29
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
- Published in:
- American Journal of Nephrology, 2023, v. 54, n. 9/10, p. 370, doi. 10.1159/000532102
- By:
- Publication type:
- Article
30
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
- Published in:
- Autophagy, 2017, v. 13, n. 10, p. 1767, doi. 10.1080/15548627.2017.1356977
- By:
- Publication type:
- Article
31
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes.
- Published in:
- Yonsei Medical Journal, 2022, v. 63, n. 6, p. 539, doi. 10.3349/ymj.2022.63.6.539
- By:
- Publication type:
- Article
32
Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
- Published in:
- Yonsei Medical Journal, 2017, v. 58, n. 2, p. 312, doi. 10.3349/ymj.2017.58.2.312
- By:
- Publication type:
- Article
33
Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.
- Published in:
- Yonsei Medical Journal, 2016, v. 57, n. 6, p. 1395, doi. 10.3349/ymj.2016.57.6.1395
- By:
- Publication type:
- Article
34
A dual-reporter system for specific tracing of pancreatic ß-cell lines that non-invasively measures viable in vivo islet cells.
- Published in:
- Biotechnology Letters, 2010, v. 32, n. 1, p. 53, doi. 10.1007/s10529-009-0113-3
- By:
- Publication type:
- Article
35
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
36
The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment.
- Published in:
- International Journal of Neuropsychopharmacology, 2012, v. 15, n. 1, p. 135, doi. 10.1017/S1461145711001611
- By:
- Publication type:
- Article
37
Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies.
- Published in:
- Scientific Reports, 2016, p. 24013, doi. 10.1038/srep24013
- By:
- Publication type:
- Article
38
Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.880164
- By:
- Publication type:
- Article
39
The effect of insulin resistance on postprandial triglycerides in Korean type 2 diabetic patients.
- Published in:
- Acta Diabetologica, 2014, v. 51, n. 1, p. 15, doi. 10.1007/s00592-012-0420-3
- By:
- Publication type:
- Article
40
Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients.
- Published in:
- Acta Diabetologica, 2012, v. 49, n. 6, p. 413, doi. 10.1007/s00592-011-0360-3
- By:
- Publication type:
- Article
41
Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients.
- Published in:
- Acta Diabetologica, 2011, v. 48, n. 2, p. 167, doi. 10.1007/s00592-010-0242-0
- By:
- Publication type:
- Article
42
Association between serum beta-hydroxybutyrate levels and risk of type 2 diabetes mellitus in patients with impaired fasting glucose.
- Published in:
- Nutrition & Diabetes, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41387-025-00364-z
- By:
- Publication type:
- Article
43
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75288-y
- By:
- Publication type:
- Article
44
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63803-0
- By:
- Publication type:
- Article
45
Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1506, doi. 10.3390/biom13101506
- By:
- Publication type:
- Article
46
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1598, doi. 10.1111/jgh.16261
- By:
- Publication type:
- Article
47
Waist‐to‐calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
48
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15983-6
- By:
- Publication type:
- Article
49
Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes.
- Published in:
- Frontiers in Endocrinology, 2018, p. N.PAG, doi. 10.3389/fendo.2018.00691
- By:
- Publication type:
- Article
50
Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus.
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00412
- By:
- Publication type:
- Article